Gold and silver extended their historic sell-off on Monday, with spot prices tumbling as much as 4% in early trading. The dramatic reversal follows a record-breaking rally that had lifted precious metals to unprecedented heights, stunning veteran traders and analysts alike.
As Nvidia's Blackwell and Rubin chips push power densities to unprecedented levels, the $4 trillion AI revolution faces a formidable physical constraint: heat. Vertiv Holdings, a critical infrastructure provider, is emerging as an essential player in solving this thermal challenge, with surging demand signaling a major shift in data center economics.
As average credit card APRs soar past 20%, a proposed 10% rate cap ignites a fierce debate between consumer advocates and the banking industry over access to credit and the future of rewards.
President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank sets the stage for a pivotal confirmation battle, raising questions about monetary policy direction and the erosion of the Fed's political firewall.
Former Federal Reserve Governor Kevin Warsh has been nominated by former President Donald Trump to chair the central bank, a move lauded by business leaders who cite his crisis-era experience and market savvy.
The Walt Disney Company's board of directors is set to meet next week, with sources indicating a final vote on the long-awaited CEO succession plan is imminent. The decision comes as Bob Iger's contract nears its end and follows a turbulent period of leadership transition at the media giant.
President Trump nominates former Fed governor Kevin Warsh to lead the central bank, setting the stage for a potential shift in monetary policy and a test of the institution's famed independence.
Private equity giant Thoma Bravo is exploring a sale of Imprivata, a key player in healthcare digital identity software, in a deal that could value the company at up to $7 billion, sources tell Reuters.
SoFi CEO Anthony Noto calls the Powell Fed era a mixed bag, praising the ultimate economic stability despite policy stumbles. As the baton passes to a new Treasury Secretary, investors weigh SoFi's record growth against a cautious 2026 outlook.
As the Federal Reserve signals potential rate cuts, income-focused investors are re-evaluating their portfolios. We analyze seven dividend ETFs that offer resilient income streams and capital appreciation potential when bond yields decline.
Oracle shares face continued pressure over debt and AI infrastructure costs, but Guggenheim's bullish $400 price target suggests potential for a multi-year rebound if execution risks are managed.
Nebius Group secures a pivotal government contract to operate Israel's national AI supercomputer, boosting its credibility and positioning it at the heart of the country's tech ecosystem, as analysts eye its growth potential.
Zeta Global Holdings (NYSE: ZETA) is drawing increased attention from Wall Street, with multiple firms raising price targets amid early 2026 momentum. Analysts point to strategic AI partnerships and sector recovery prospects as key drivers.
Wix.com Ltd. has launched a major share repurchase program as its stock trades near multi-year lows. While analysts have trimmed price targets, many maintain bullish ratings, citing significant upside potential and a more resilient outlook for SaaS companies in the face of AI disruption.
HubSpot (NYSE: HUBS) is drawing sustained bullish sentiment from Wall Street, with analysts highlighting its deepening penetration into the large enterprise segment as a key growth driver. Recent price target adjustments and partner commentary underscore confidence in the CRM platform's trajectory.
Senator Lindsey Graham has stalled a bipartisan funding deal to avert a shutdown, demanding the restoration of a controversial provision allowing lawmakers to sue the Justice Department for damages—a move critics decry as a self-serving scheme.
CNBC's Jim Cramer suggests Intel shares could surge significantly, as the chipmaker's strategic overhaul and analyst upgrades fuel investor optimism amid a 140% yearly gain.
The fourth-quarter earnings season for diversified banks revealed a tale of divergence. While PNC Financial surprised to the upside, industry titan Citigroup fell short of expectations, highlighting the uneven pressures facing the sector.
Boston Scientific (BSX) is attracting bullish analyst attention after its strategic acquisition of Penumbra, with Truist Securities reiterating a Buy rating and a $120 price target, citing enhanced business durability and growth prospects.
DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.
